282 related articles for article (PubMed ID: 19812458)
1. Cardiorespiratory fitness and preserved medial temporal lobe volume in Alzheimer disease.
Honea RA; Thomas GP; Harsha A; Anderson HS; Donnelly JE; Brooks WM; Burns JM
Alzheimer Dis Assoc Disord; 2009; 23(3):188-97. PubMed ID: 19812458
[TBL] [Abstract][Full Text] [Related]
2. Association of Asymmetrical White Matter Hyperintensities and Apolipoprotein E4 on Cognitive Impairment.
Low A; Ng KP; Chander RJ; Wong B; Kandiah N
J Alzheimers Dis; 2019; 70(3):953-964. PubMed ID: 31306121
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E and gray matter volume loss in patients with mild cognitive impairment and Alzheimer disease.
Spampinato MV; Rumboldt Z; Hosker RJ; Mintzer JE;
Radiology; 2011 Mar; 258(3):843-52. PubMed ID: 21163916
[TBL] [Abstract][Full Text] [Related]
4. Cardiorespiratory fitness and brain atrophy in early Alzheimer disease.
Burns JM; Cronk BB; Anderson HS; Donnelly JE; Thomas GP; Harsha A; Brooks WM; Swerdlow RH
Neurology; 2008 Jul; 71(3):210-6. PubMed ID: 18625967
[TBL] [Abstract][Full Text] [Related]
5. Nonlinear cerebral atrophy patterns across the Alzheimer's disease continuum: impact of APOE4 genotype.
Gispert JD; Rami L; Sánchez-Benavides G; Falcon C; Tucholka A; Rojas S; Molinuevo JL
Neurobiol Aging; 2015 Oct; 36(10):2687-701. PubMed ID: 26239178
[TBL] [Abstract][Full Text] [Related]
6. APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD.
Geroldi C; Pihlajamäki M; Laakso MP; DeCarli C; Beltramello A; Bianchetti A; Soininen H; Trabucchi M; Frisoni GB
Neurology; 1999 Nov; 53(8):1825-32. PubMed ID: 10563634
[TBL] [Abstract][Full Text] [Related]
7. The APOE4 effect: structural brain differences in Alzheimer's disease according to the age at symptom onset.
Forno G; Contador J; Pérez-Millan A; Guillen N; Falgàs N; Sarto J; Tort-Merino A; Castellví M; Bosch B; Fernández-Villullas G; Balasa M; Antonell A; Sala-Llonch R; Sanchez-Valle R; Hornberger M; Lladó A
Eur J Neurol; 2023 Mar; 30(3):597-605. PubMed ID: 36463489
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia.
Agosta F; Vossel KA; Miller BL; Migliaccio R; Bonasera SJ; Filippi M; Boxer AL; Karydas A; Possin KL; Gorno-Tempini ML
Proc Natl Acad Sci U S A; 2009 Feb; 106(6):2018-22. PubMed ID: 19164761
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive dissection of the medial temporal lobe in AD: measurement of hippocampus, amygdala, entorhinal, perirhinal and parahippocampal cortices using MRI.
Teipel SJ; Pruessner JC; Faltraco F; Born C; Rocha-Unold M; Evans A; Möller HJ; Hampel H
J Neurol; 2006 Jun; 253(6):794-800. PubMed ID: 16511646
[TBL] [Abstract][Full Text] [Related]
10. Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease.
Filippini N; Rao A; Wetten S; Gibson RA; Borrie M; Guzman D; Kertesz A; Loy-English I; Williams J; Nichols T; Whitcher B; Matthews PM
Neuroimage; 2009 Feb; 44(3):724-8. PubMed ID: 19013250
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias.
Barber R; Gholkar A; Scheltens P; Ballard C; McKeith IG; Morris CM; O'Brien JT
Arch Neurol; 1999 Aug; 56(8):961-5. PubMed ID: 10448801
[TBL] [Abstract][Full Text] [Related]
12. Association of APOE ε4 with cerebral gray matter volumes in non-demented older adults: The MEMENTO cohort study.
Régy M; Dugravot A; Sabia S; Fayosse A; Mangin JF; Chupin M; Fischer C; Bouteloup V; Dufouil C; Chêne G; Paquet C; Hanseeuw B; Singh-Manoux A; Dumurgier J;
Neuroimage; 2022 Apr; 250():118966. PubMed ID: 35122970
[TBL] [Abstract][Full Text] [Related]
13. Impact of APOE on the healthy aging brain: a voxel-based MRI and DTI study.
Honea RA; Vidoni E; Harsha A; Burns JM
J Alzheimers Dis; 2009; 18(3):553-64. PubMed ID: 19584447
[TBL] [Abstract][Full Text] [Related]
14. Inferior temporal lobe atrophy and APOE genotypes in Alzheimer's disease. X-ray computed tomography, magnetic resonance imaging and Xe-133 SPECT studies.
Tanaka S; Kawamata J; Shimohama S; Akaki H; Akiguchi I; Kimura J; Ueda K
Dement Geriatr Cogn Disord; 1998; 9(2):90-8. PubMed ID: 9524800
[TBL] [Abstract][Full Text] [Related]
15. Multicentre variability of MRI-based medial temporal lobe volumetry in Alzheimer's disease.
Teipel SJ; Ewers M; Wolf S; Jessen F; Kölsch H; Arlt S; Luckhaus C; Schönknecht P; Schmidtke K; Heuser I; Frölich L; Ende G; Pantel J; Wiltfang J; Rakebrandt F; Peters O; Born C; Kornhuber J; Hampel H
Psychiatry Res; 2010 Jun; 182(3):244-50. PubMed ID: 20493672
[TBL] [Abstract][Full Text] [Related]
16. Cardiorespiratory fitness is associated with atrophy in Alzheimer's and aging over 2 years.
Vidoni ED; Honea RA; Billinger SA; Swerdlow RH; Burns JM
Neurobiol Aging; 2012 Aug; 33(8):1624-32. PubMed ID: 21531480
[TBL] [Abstract][Full Text] [Related]
17. Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676 AD, MCI, and normal subjects.
Hua X; Leow AD; Parikshak N; Lee S; Chiang MC; Toga AW; Jack CR; Weiner MW; Thompson PM;
Neuroimage; 2008 Nov; 43(3):458-69. PubMed ID: 18691658
[TBL] [Abstract][Full Text] [Related]
18. Neuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriers.
Chételat G; Fouquet M
Rev Neurol (Paris); 2013 Oct; 169(10):729-36. PubMed ID: 24016463
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E ε4 Modulates Cognitive Profiles, Hippocampal Volume, and Resting-State Functional Connectivity in Alzheimer's Disease.
Wang X; Wang J; He Y; Li H; Yuan H; Evans A; Yu X; He Y; Wang H
J Alzheimers Dis; 2015; 45(3):781-95. PubMed ID: 25624419
[TBL] [Abstract][Full Text] [Related]
20. Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease.
Honea RA; Swerdlow RH; Vidoni ED; Goodwin J; Burns JM
Neurology; 2010 Jan; 74(2):113-20. PubMed ID: 20065246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
